373267003: Antilipemic agent (substance)

SNOMED CT Concept\Substance\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Antilipemic agent (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Antilipemic agent (substance)	Is a	Cardiovascular agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fibrate antihyperlipidemic	Is a	False	Antilipemic agent (substance)	Inferred relationship	Some
Anion exchange resin	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Bile acid sequestrant antilipemic agent (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
HMG-CoA reductase inhibitor	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Lipid-lowering drug adverse reaction	Causative agent (attribute)	True	Antilipemic agent (substance)	Inferred relationship	Some	1
Dextrothyroxine sodium adverse reaction	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Acipimox adverse reaction	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Fish oils adverse reaction	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Omega 3-marine triglycerides adverse reaction	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Lipid-lowering drug allergy	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
allergie à la dextrothyroxine sodique	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Allergy to fish oil	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Allergy to fish derived omega 3 fatty acid	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Lipid-lowering drug overdose	Causative agent (attribute)	True	Antilipemic agent (substance)	Inferred relationship	Some	1
Probucol (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Gemfibrozil (substance)	Is a	False	Antilipemic agent (substance)	Inferred relationship	Some
Clofibrate (substance)	Is a	False	Antilipemic agent (substance)	Inferred relationship	Some
Acipimox	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Cholesterol-lowering drug	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Adverse reaction to antilipemic and antiarteriosclerotic drugs NOS	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some
Ezetimibe (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Policosanol (substance)	Is a	False	Antilipemic agent (substance)	Inferred relationship	Some
Dextrothyroxine sodium	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 3.4g/sachet s/f powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 6g/sachet s/f powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Senna+ispaghula 12.4%/54.2% granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 3.5g/sachet s/f granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Omega 3-marine triglycerides	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Fish derived omega 3 fatty acid 1 g oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Fish oil (concentrate) oral liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing fish derived omega 3 fatty acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing ispaghula husk (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing docosahexaenoic acid and eicosapentaenoic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Omega-3 acid ethyl ester 1g soft gelatin capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
médicament hypolipémiant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing psyllium and senna (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk [gastro-intestinal bulk laxative]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 56% powder 6.4g	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk [lipid lowering use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 3.5g/sachet s/f powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Product containing ispaghula husk and mebeverine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Ispaghula husk 3.5g effervescent granules sachets gluten free sugar free	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Peroxisome proliferator-activated alpha receptor agonist	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Lipid-lowering drug allergy	Causative agent (attribute)	False	Antilipemic agent (substance)	Inferred relationship	Some	1
Tiadenol (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Product containing 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Antilipemic agent (substance)	Inferred relationship	Some
Evolocumab (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Mipomersen (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Lomitapide (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Benfluorex (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Lomitapide mesilate (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Mipomersen sodium (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Dextrothyroxine	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Levocarnitine	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Loteprednol (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Bempedoic acid (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Loteprednol etabonate (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Evinacumab (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Inclisiran (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Nicofuranose (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Inclisiran sodium (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some
Eicosapentaenoic acid ethyl ester (substance)	Is a	True	Antilipemic agent (substance)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198564013	Antilipemic agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1207436017	Antilipaemic agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1208248015	Antilipemic agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1229194014	Lipid lowering agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
189741000077116	agent hypolipémiant	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module